PURPOSE: to grant discharge to the IMI 2 Joint Undertaking for the financial year 2016.
NON-LEGISLATIVE ACT: Decision (EU) 2018/1448 of the European Parliament on discharge in respect of the implementation of the budget of the Innovative Medicines Initiative 2 Joint Undertaking for the financial year 2016.
CONTENT: the European Parliament decided to grant discharge to the Executive Director of the Innovative Medicines Initiative 2 Joint Undertaking for the financial year 2016.
This decision is accompanied by a resolution of the European Parliament containing the observations which form an integral part of the discharge decision in respect of the implementation of the general budget of the European Union for the financial year 2016 (please refer to the summary dated 18.4.2018).
In this resolution, Parliament regretted to note that at the end of 2016 — the third year of Horizon 2020 implementation — the IMI 2 Joint Undertaking had only partially completed the integration of its control systems with the Commission’s common Horizon 2020 grant management and monitoring tools. Prioritisation is to be given to complete the integration process quickly according to Parliament.
It acknowledged, however, the significant progress achieved in close cooperation with the Commission services which should enable all IMI 2 Joint Undertaking project reporting, monitoring and payment to be carried out via the common Horizon 2020 tools as of the beginning of 2018.
Lastly, Parliament called on the Commission to ensure the direct involvement of the IMI 2 Joint Undertaking in the process of the Horizon 2020 mid-term review in the sphere of further simplifications and harmonisation of joint undertakings.